HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) An erratum has been published Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Metcalf, D. Articles by Mifsud, S. Search for Related Content PubMed PubMed Citation Articles by Metcalf, D. Articles by Mifsud, S.

Synergistic and Inhibitory Interactions in the In Vitro Control of Murine Megakaryocyte Colony Formation

Division of Cancer and Hematology, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia

Key Words. Megakaryocyte colonies • Synergy • Interleukin-3 • Erythropoietin • Thrombopoietin

Donald Metcalf, M.D., Division of Cancer and Hematology, The Walter and Eliza Hall Institute of Medical Research, Post Office Royal Melbourne Hospital, Victoria 3050 Australia. Telephone: 61-3-9345-2555; Fax: 61-3-9347-0852; e-mail: metcalf{at}wehi.edu.au

The formation of megakaryocyte colonies in agar cultures of murine bone marrow or spleen cells can be stimulated by the addition of interleukin-3 (IL-3), erythropoietin (EPO), thrombopoietin (TPO), or IL-6. However, greater numbers of colonies developed if combinations of two or more of these stimuli were used, particularly combinations including stem cell factor, with maximal numbers of colonies developing with the combination of stem cell factor plus IL-3 plus EPO. The data indicate that most committed progenitor cells in the megakaryocyte lineage were unusual in that they required stimulation by two or more hematopoietic growth factors. In tests using a range of growth factors, G-CSF was exceptional in that it consistently specifically inhibited megakaryocyte colony formation stimulated by EPO, TPO, or IL-6 but not that stimulated by IL-3. The mechanisms involved in this inhibitory action of G-CSF are unknown, but the inhibitory action could be of relevance for the dose-dependent lowering of platelet levels observed in some subjects injected with G-CSF.

This article has been cited by other articles:

				D. Metcalf Hematopoietic cytokines Blood, January 15, 2008; 111(2): 485 - 491. [Abstract] [Full Text] [PDF]

				D. P. Smith, M. L. Bath, D. Metcalf, A. W. Harris, and S. Cory MYC levels govern hematopoietic tumor type and latency in transgenic mice Blood, July 15, 2006; 108(2): 653 - 661. [Abstract] [Full Text] [PDF]

				A. Dakic, D. Metcalf, L. Di Rago, S. Mifsud, L. Wu, and S. L. Nutt PU.1 regulates the commitment of adult hematopoietic progenitors and restricts granulopoiesis J. Exp. Med., May 2, 2005; 201(9): 1487 - 1502. [Abstract] [Full Text] [PDF]

				G. Terszowski, C. Waskow, P. Conradt, D. Lenze, J. Koenigsmann, D. Carstanjen, I. Horak, and H.-R. Rodewald Prospective isolation and global gene expression analysis of the erythrocyte colony-forming unit (CFU-E) Blood, March 1, 2005; 105(5): 1937 - 1945. [Abstract] [Full Text] [PDF]

				S. L. Nutt, D. Metcalf, A. D'Amico, M. Polli, and L. Wu Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors J. Exp. Med., January 18, 2005; 201(2): 221 - 231. [Abstract] [Full Text] [PDF]

				D. Metcalf, S. Mifsud, and L. Di Rago Murine Megakaryocyte Progenitor Cells and Their Susceptibility to Suppression by G-CSF Stem Cells, January 1, 2005; 23(1): 55 - 62. [Abstract] [Full Text] [PDF]